Hsp27 as an anti-inflammatory protein

Molecular Chaperones and Cell Signalling

Volumn , Issue , 2005, Pages 220-223

  Laudanski, Krzysztof ^a   de Asit, K ^a   Miller Graziano, Carol L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926982536     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546310.014     Document Type: Chapter

References (35)

1. Wick G, Knof lach M and Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Ann Rev Immunol 2004, 22: 361-403.
2. Tsan M F and Gao B. Cytokine function of heat shock proteins. Am J Physiol Cell Physiol 2004, 286: C739-C744.
3. Feder M E and Hof mann G E. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Ann Rev Physiol 1999, 61: 243-282.
4. Jaattela M and Wissing D. Emerging role of heat shock proteins in biology and medicine. Ann Med 1992, 24: 249-258.
5. Ohashi K, Burkart V, Flohe S and Kolb H. Heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J Immunol 2000, 164: 558-561.
6. Zanin-Zhorov A, Nussbaum G, Franitza S, Cohen I R and Lider O. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J 2003, 17: 1567-1569.
7. Fanelli M A, Cuello Carrion F D, Dekker J, Schoemaker J and Ciocca D R. Serological detection of heat shock protein hsp27 in normal and breast cancer patients. Canc Epidemiol Biomarkers Prev 1998, 7: 791-795.
8. Wissing D and Jaattela M. HSP27 and HSP70 increase the survival of wEHI-S cells exposed to hyperthermia. Int J Hyperthermia 1996, 12: 125-138.
9. Korneeva I, Bongiovanni A M, Girotra M, Caputo T A and Witkin S S. IgA antibodies to the 27-kDa heat-shock protein in the genital tracts of women with gynecologic cancers. IntJ Cancer 2000, 87: 824-828.
10. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo A P, Chauffert B and Mehlen P. Hsp27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 1997, 57: 2661-2667.
11. Korneeva I, Caputo T A and Witkin S S. Cell-free 27 kDa heat shock protein (hsp27) and hsp27-cytochrome c complexes in the cervix of women with ovarian or endometrial cancer. IntJ Cancer 2002, 102: 483-486.
12. Jaattela M and Wissing D. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J Exp Med 1993, 177: 231-236.
13. Conroy S E, Sasieni P D, Amin V, Wang D Y, Smith P, Fentiman I S and Latchman D S. Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Br J Cancer 1998, 77: 1875-1879.
14. Carter Y, Liu G, Stephens W B, Carter G, Yang J and Mendez C. Heat shock protein (HSP72) and p38 MAPK involvement in sublethal hemorrhage (SLH)-induced tolerance. J Surg Res 2003, 111: 70-77.
15. De A K, Kodys KM, Yeh B S and Miller-Graziano C. Exaggerated human monocyte IL-10 concomitant to minimal TNF-a induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an anti-inflammatory stimulus. J Immunol 2000, 165: 3951-3958.
16. Asea A, Rehli M, Kabingu E, Boch J A, Baris O, Auron P E, Stevenson M A and Calderwood S K. Novel signal transduction pathway utilized by extracellular HSP70. Role of Toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002, 277: 15028-15034.
17. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Ann Rev Immunol 2002, 20: 395-425.
18. Moore K W, de Waal Malefyt R, Coffman R L and O’Garra A. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol 2001, 19: 683-765.
19. Hwang D. Fatty acids and immune responses - a new perspective in searching for clues to mechanism. Ann Rev Nutr 2000, 20: 431-456.
20. Hashimoto S, Yamada M, Motoyoshi K and Akagawa K S. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 1997, 89: 315-321.
21. De A K, Laudanski K and Miller-Graziano C L. Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage- colony-stimulating factor-driven macrophage differentiation. J Immunol 2003, 170: 6355-6362.
22. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y J, Pulendran B and Palucka K. Immunobiology of dendritic cells. Ann Rev Immunol 2000, 18: 767-811.
23. Dobrovolskaia M A and Vogel S N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002, 4: 903-914.
24. Triantafilou M and Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002, 23: 301-304.
25. van Amersfoort E S, van Berkel T J and Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003, 16: 379-414.
26. West M A and Heagy W. Endotoxin tolerance: a review. Crit Care Med 2002, 30(1 Supp): S64-S73.
27. Kirschning C J and Schumann R R. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 2002, 270: 121-144.
28. Habich C, Baumgart K, Kolb H and Burkart V. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J Immunol 2002, 168: 569-576.
29. Heine H, El-Samalouti V T, Notzel C, Pfeiffer A, Lentschat A, Kusumoto S, Schmitz G, Hamann L and Ulmer A J. CD55/decay accelerating factor is part of the lipopolysaccharide-induced receptor complex. Eur J Immunol 2003, 33: 1399-1408.
30. Volk H D, Reinke P and Docke W D. Clinical aspects: from systemic inflammation to ‘immunoparalysis’. Chem Immunol 2000, 74: 162-177.
31. Vabulas R M, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning C J, Hacker H and Wagner H. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001, 276: 31332-31339.
32. Guermonprez P, Valladeau J, Zitvogel L, Thiery C and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Ann Rev Immunol 2002, 20: 621-667.
33. Stevens T R, Winrow V R, Blake D R and Rampton D S. Circulating antibodies to heat-shock protein 60 in Crohn’s disease and ulcerative colitis. Clin Exp Immunol 1992, 90: 271-274.
34. Gao Y L, Raine C S and Brosnan C F. Humoral response to hsp 65 in multiple sclerosis and other neurological conditions. Neurology 1994, 44: 941-946.
35. O’Neill P A, Shaaban A M, West C R, Dodson A, Jarvis C, Moore P, Davies M P, Sibson D R and Foster C S. Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. Br J Cancer 2004, 90: 182-188.